Using AI to generate a speedier, more accurate diagnosis of a specific medical condition is a worthy and ambitious goal. But VUNO is aiming bigger. The South Korea-based startup is building an extended family of NVIDIA GPU-powered AI products, each addressing diagnoses of different diseases.
The company’s AI algorithms are designed to capitalize on the growing pools of big data associated with a vast number of conditions. So far, VUNO has products that address bone age assessment, neurodegenerative disorders and diseases with signs visible on chest X-rays or CT scans. It also has a handful of products in development focused on eye abnormalities, among other areas.
